-
Detailed Analysis Generate Full Report Add to Watchlist
Values as of: 2019-10-16
Values as of: 2019-10-16
The investment seeks to replicate as closely as possible, before fees and expenses, the performance of the S&P 500? Equal Weight Index Health Care Total Return. The underlying index is an unmanaged equal weighted version of the S&P 500? Health Care Index that consists of the common stocks of the following industries: health care equipment and supplies, health care providers and services, and biotechnology and pharmaceuticals that comprise the Health Care sector of the S&P 500? Index. The fund is non-diversified.
Company Website : www.rydex-sgi.com/
Currency: USD
Country : USA
Inception Date: 01/11/2006
Primary Benchmark: S&P 500 Equal Weighted HC TR USD
Primary Index: MSCI ACWI NR USD
Gross Expense Ratio: 0.4%
Management Expense Ratio: 0.40 %
N/A
N/A
Symbol | Company Name | Allocation |
---|---|---|
3020-OL:HK | X DBMSCIUSA | 1.64 % |
N/A
N/A
Symbol | Name | Mer | Price(Change) | Market Cap |
---|---|---|---|---|
SOJE | SOJE | 0.00 % |
-0.26 (-1.27%) |
USD 65.72B |
ITDC | Ishares Lifepath Target Date 2.. | 0.00 % |
+0.02 (+0.07%) |
USD 36.86B |
JEPI | JPMorgan Equity Premium Income.. | 0.00 % |
+0.09 (+0.16%) |
USD 32.78B |
LCR | Leuthold Core ETF | 0.00 % |
+0.03 (+0.10%) |
USD 32.52B |
DTB | DTB | 0.00 % |
+0.01 (+0.05%) |
USD 26.58B |
DFAC | Dimensional U.S. Core Equity 2.. | 0.00 % |
+0.08 (+0.25%) |
USD 26.11B |
JPST | JPMorgan Ultra-Short Income ET.. | 0.00 % |
-0.01 (-0.02%) |
USD 22.47B |
SGOV | iShares® 0-3 Month Treasury B.. | 0.00 % |
+0.01 (+0.01%) |
USD 18.58B |
TSPA | T. Rowe Price US Equity Resear.. | 0.00 % |
+0.06 (+0.18%) |
USD 16.23B |
DFUV | Dimensional US Marketwide Valu.. | 0.00 % |
+0.20 (+0.49%) |
USD 10.15B |
Symbol | Name | Weight | Mer | Price(Change) | Market Cap |
---|---|---|---|---|---|
QRH:CA | 0.00 % | 1.20 % |
N/A |
N/A |
Market Performance vs. Industry/Classification (Others) | Market Performance vs. Exchange (NYSE Arca) | ||||||
Value | Sector Median | Percentile Rank | Grade | Market Median | Percentile Rank | Grade | |
YTD | |||||||
Capital Gain | 11.19% | 53% | F | 49% | F | ||
Dividend Return | 0.49% | 9% | A- | 7% | C- | ||
Total Return | 11.68% | 47% | F | 44% | F | ||
Trailing 12 Months | |||||||
Capital Gain | -0.71% | 36% | F | 43% | F | ||
Dividend Return | 0.44% | 6% | D- | 5% | F | ||
Total Return | -0.28% | 30% | F | 38% | F | ||
Trailing 5 Years | |||||||
Capital Gain | 59.21% | 88% | B+ | 80% | B- | ||
Dividend Return | 3.17% | 16% | F | 11% | F | ||
Total Return | 62.37% | 84% | B | 76% | C+ | ||
Average Annual (5 Year Horizon) | |||||||
Capital Gain | 6.84% | 80% | B- | 72% | C | ||
Dividend Return | 7.31% | 74% | C | 64% | D | ||
Total Return | 0.47% | 17% | F | 12% | F | ||
Risk Return Profile | |||||||
Volatility (Standard Deviation) | 8.44% | 62% | D | 78% | C+ | ||
Risk Adjusted Return | 86.60% | 82% | B | 84% | B | ||
Market Capitalization | 0.47B | 77% | C+ | 51% | F |
Target Price Action | Rating Action | Analyst | Rating | Price | Date |
---|
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
The company has under performed its peers on annual average total returns in the past 5 years.